Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 17,321–17,340 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass I

BLUE Diamond PLATINUM Capsules, 1000 mg, supplied in 1, 5 and 10 count blister packs, Distributed By: DH Distribution Los Angeles, CA 90026 1 count blister UPC -608641933543; 5 count blister UPC - 608641932867; 10 count UPC -608641933536

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

BLUE Diamond Pill, supplied in 1, 5 and 10 count blister packs, Male Sexual Enhancement, Distributed By: DH Distribution Los Angeles, CA 90026. 1 count blister: UPC 705105524764, 5 count blister: UPC 736211124012, 10 count blister: UPC 736211123916.

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

libigrow XXXTREME Capsules, MAXIMUM STRENGTH FORMULA, 1000 mg, supplied in 1, 5 and 10 count blister packs, Distributed By Kretek International, Inc. Moorpark, CA 930210 1 count blister: UPC 705105830735, 5 count blister: UPC 610585435939, 10 count blister: UPC 610585435922.

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

libigrow capsules, PERFORMANCE ENHANCER, supplied in 1, 5 and 10 count blister packs, Distributed By: H & K Nutraceuticals Los Angeles, CA 1 count blister: UPC 094922567611, 5 count blister: UPC 094922567628, 10 count blister: UPC 610585434253.

by Performance Plus Marketing, Inc.

Reason
Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs
Recall initiated
December 17, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for : Glenmark Generics USA Mahwah, NJ 07430

by Glenmark Generics Inc., USA

Reason
Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.
Recall initiated
April 5, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Glenmark Pravastatin Sodium Tablets ,40 mg, 90-count bottle (NDC 68462-197-90), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for :Glenmark Generics USA Mahwah, NJ 07430

by Glenmark Generics Inc., USA

Reason
Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to an off-odor described as moldy, musty or fishy in nature.
Recall initiated
April 5, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Glenmark Gabapentin Tablets, a) 600mg, 500- count bottle (NDC 68462-126-05), b) 800 mg, 500- count bottle (NDC 68462-127-05), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India, Manufactured for : Glenmark Generics USA Mahwah, NJ 07430.

by Glenmark Generics Inc., USA

Reason
Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off - odor described as moldy, musty or fishy in nature.
Recall initiated
April 5, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Mojo Nights for Her, 1 capsule, UPC 7 18122 12133 5, Distributed By: Mojo Health Lauderhill, FL 33351

by Evol Nutrition

Reason
Marketed Without an Approved NDA/ANDA: The products were found to contain FDA approved ingredients and analogues of FDA approved ingredients used to treat male erectile dysfunction, making them unapproved new drugs.
Recall initiated
August 23, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Mojo Nights, 1 capsule, UPC 7 18122 11983 7, Distributed By: Mojo Health Lauderhill, FL 33351

by Evol Nutrition

Reason
Marketed Without an Approved NDA/ANDA: The products were found to contain FDA approved ingredients and analogues of FDA approved ingredients used to treat male erectile dysfunction, making them unapproved new drugs.
Recall initiated
August 23, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

a) Firminite 805 mg is packaged in 2 count, 4 count, and 10 count capsules blister packs in a box, WWW.FIRMINITE.COM, b) Libidron 410 mg is packaged in 2 count, 4 count, and 10 count capsules blister packs in a box, WWW.LIBIDRON.COM , c)Extra Strength Instant Hot Rod 496 mg is packaged in 4 count and 10 count capsule blister packs in a box, www.HotRodExtraStrength.com

by InSo-Independent Contractor for West Coast Nutritionals,LTD

Reason
Marketed Without an Approved NDA/ANDA: These products found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making these products unapproved new drugs.
Recall initiated
May 18, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide in the United States, U.S. Virgin Islands, Puerto Rico and to the following locations: United Kingdom, United Arab Emirates, Turkey, Trinidad & Tobago, Thailand, Taiwan, Sweden, St. Maarten, Spain, South Africa, Singapore, Saudi Arabia, Russia, Romania, Qatar, Portugal, Poland, Philippines, Papua New Guinea, Pakistan, Oman, Norway, Nigeria, New Zealand, Netherlands Antilles, Netherlands, Mozambique, Montenegro, Mauritius, Malta, Maldives, Malaysia, Latvia, Kuwait, South Korea, J

View recall →

Drug Recall Terminated Historical recordClass I

ROCK-IT MAN capsules, male sexual stimulant, packaged in 1-count (UPC 8 53447 02003 8) and 2-count (UPC 8 53447 00204 1) blister cards, Distributed by Consumer Concepts.

by Consumer Concepts, Inc.

Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain hydroxythiohomosildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
Recall initiated
April 1, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

by Gilead Sciences, Inc.

Reason
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Recall initiated
January 31, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.

View recall →

Drug Recall Terminated Historical recordClass I

Super Power capsules, Proprietary Blend 570 mg, packaged in 2-count capsules per blister pack, Distributed by: Freedom Trading, NJ 08863, UPC 7 18122 90678 9.

by D& S Herbals, LLC

Reason
Marketed Without An Approved NDA/ANDA: This dietary supplement has been found to contain sildenafil, an FDA approved drug for the treatment of male erectile dysfunction making this an unapproved new drug.
Recall initiated
December 22, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Cyanocobalamin 1000 mcg/ml, injection 30 mL, MDV, For Office Use Only, Green Valley Drugs, Manufactured by Green Valley Drugs, Henderson, NV.

by Green Valley Drugs

Reason
Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.
Recall initiated
December 4, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Methylprednisolone Preservative Free 40 mg/ml Injectible Suspension, 1 mL Vials and 2 mL Vials and 1 mL pre-filled syringes, For Office Use Only, Manufactured by Green Valley Drugs, Henderson, NV.

by Green Valley Drugs

Reason
Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.
Recall initiated
December 4, 2012
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY. Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ. Distributed by: Wal-Mart Stores, Inc., Bentonville, AR. Packaged by: Legacy Pharmaceutical Packaging, LLC, Earth City, MO. NDC 68645-445-70.

by Legacy Pharmaceutical Packaging LLC

Reason
Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description. Tablet strength is 10 mg.
Recall initiated
April 22, 2013
Reported by FDA
May 22, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

by L. Perrigo Co.

Reason
Failed Impurities/Degradation Specifications: 3 month stability testing.
Recall initiated
March 12, 2013
Reported by FDA
May 15, 2013
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Plavix 75 mg, 30 count bottle, NDC (54868-4070-0), Rx only, Manufactured by Bristol-Meyers Squibb, Bridgewater, NJ 08807, Distributed by Physicians Total Care, Tulsa, OK 74146.

by Physicians Total Care, Inc.

Reason
Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).
Recall initiated
February 8, 2011
Reported by FDA
May 15, 2013
Distribution
NC

View recall →

Drug Recall Terminated Historical recordClass II

Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-7299-73

by Hospira Inc.

Reason
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Recall initiated
February 26, 2013
Reported by FDA
May 15, 2013
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02

by Hospira Inc.

Reason
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Recall initiated
February 26, 2013
Reported by FDA
May 15, 2013
Distribution
Nationwide and Puerto Rico

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.